Aurinia Pharmaceuticals, Inc. (AUPH)

16.42 +0.60 (+3.79%) USD  |  NASDAQ  |  Apr 22, 16:00
16.35 -0.07 (-0.43%) After-Hours: 06:12
More

Aurinia Pharmaceuticals Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for AUPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Xenon Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
ProMIS Neurosciences, Inc. Upgrade